Firoz Akhter Selected Research

Advanced Glycation End Products

1/2021	The Neoepitopes on Methylglyoxal- (MG-) Glycated Fibrinogen Generate Autoimmune Response: Its Role in Diabetes, Atherosclerosis, and Diabetic Atherosclerosis Subjects.
1/2020	High Dietary Advanced Glycation End Products Impair Mitochondrial and Cognitive Function.
2/2019	The non-enzymatic glycation of LDL proteins results in biochemical alterations - A correlation study of Apo B100-AGE with obesity and rheumatoid arthritis.
1/2018	Do all roads lead to the Rome? The glycation perspective!
4/2016	Antigenic role of the adaptive immune response to d-ribose glycated LDL in diabetes, atherosclerosis and diabetes atherosclerotic patients.
8/2014	Immunogenicity of DNA-advanced glycation end product fashioned through glyoxal and arginine in the presence of Fe³⁺: its potential role in prompt recognition of diabetes mellitus auto-antibodies.
1/2014	An immunohistochemical analysis to validate the rationale behind the enhanced immunogenicity of D-ribosylated low density lipo-protein.
11/2013	Studies on glycation of human low density lipoprotein: a functional insight into physico-chemical analysis.
7/2013	Bio-physical characterization of ribose induced glycation: a mechanistic study on DNA perturbations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Firoz Akhter Research Topics

Disease

5	Type 2 Diabetes Mellitus (MODY) 01/2024 - 08/2014
4	Diabetes Mellitus 01/2024 - 08/2014
4	Atherosclerosis 01/2021 - 11/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2023 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 01/2020
2	Cognitive Dysfunction 12/2023 - 01/2020
2	Dehydration (Water Stress) 11/2014 - 07/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024
1	Neuroinflammatory Diseases 12/2023
1	Hyperglycemia 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Inflammation (Inflammations) 02/2019
1	Obesity 02/2019
1	Rheumatoid Arthritis 02/2019
1	Arthritis (Polyarthritis) 02/2019
1	Hypoxia (Hypoxemia) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Diabetes Complications 04/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2014
1	Renal Insufficiency (Renal Failure) 01/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2014

Drug/Important Bio-Agent (IBA)

9	Advanced Glycation End ProductsIBA 01/2021 - 07/2013
6	oxidized low density lipoproteinIBA 01/2020 - 11/2013
6	AntibodiesIBA 01/2020 - 08/2014
4	LDL glycated lipoproteinsIBA 02/2019 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2016
3	Ribose (D-Ribose)IBA 02/2019 - 04/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 07/2013
2	AutoantibodiesIBA 01/2021 - 02/2019
2	AntigensIBA 02/2019 - 01/2015
2	SugarsIBA 11/2014 - 07/2013
1	Amyloid (Amyloid Fibrils)IBA 05/2024
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2024
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2024
1	Vitamin D FDA LinkGeneric 01/2024
1	ebselenIBA 12/2023
1	Peptidyl-Prolyl Isomerase FIBA 12/2023
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 12/2023
1	Amyloid beta-PeptidesIBA 12/2023
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 12/2023
1	Cyclophilins (Cyclophilin)IBA 12/2023
1	glycated fibrinogenIBA 01/2021
1	Fibrinogen (Factor I)FDA Link 01/2021
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2021
1	Dietary Advanced Glycation End ProductsIBA 01/2020
1	LipidsIBA 02/2019
1	CateninsIBA 01/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Apolipoprotein B-100 (Apo B 100)IBA 03/2017
1	Schiff Bases (Schiff Base)IBA 11/2014
1	Arginine (L-Arginine)FDA Link 08/2014
1	Glyoxal (Ethanedial)IBA 08/2014
1	Lipoproteins (Lipoprotein)IBA 01/2014